The data from the 11 dataset cohorts and an independent clinical sample set show that OAS1, IFIT1, and IFIT3 were included and evaluated in the multi-combined diagnostic biomarkers in discriminating TB from the control or other disease groups, and were thus regarded as distinctive combined biomarkers of PTB. This evidence concerns the gene IFIT3 and tuberculosis.